General Division of the High Court · Decided 12 January 2026
Claims in negligence over a patient's treatment failed; the standard of care was met
Parvaty d/o Raju and another v National University Hospital (S) Pte Ltd and another
Feedback & support[2026] SGHC 7 · Case no. Originating Claim No 468 of 2022
✱ The decision, in one line
Not legal advice
Claims in negligence over a patient's treatment failed; the standard of care was met
Summary by laws.sg·Paragraph [237]
There is no fuller plain-English summary of this judgment yet.
Ask about this judgment →Laws this judgment relies on
Grounds of decision
Official text from eLitigation
Introduction
- [1]
[1] The first claimant named in this suit is Mdm Parvaty d/o Raju (“Mdm Parvaty”), who passed away on 30 January 2023. The second claimant named in this suit is Mdm Meenachi d/o Suppiah (“Mdm Meenachi”), who is Mdm Parvaty’s daughter and the administrator of her estate.
- [2]
[2] The first defendant is National University Hospital (“NUH”), which provides hospital services including specialised medical care, treatment and services including vascular surgery, orthopaedics, infectious diseases, podiatry
and wound nursing. The second defendant is Ang Mo Kio – Thye Hua Kwan Hospital Ltd (“AMKH”), a community hospital providing medical, nursing, and rehabilitation care management, treatment, and services. These include, inter alia, medical services for patients who require a short period of continuation of care following their discharge from an acute care hospital.
- [3]
[3] In the present suit, Mdm Parvaty and Mdm Meenachi pleaded various breaches of duties owed to Mdm Parvaty by both NUH and AMKH (collectively the “Defendants”). The Defendants were said to be vicariously liable for the breaches of duties by their staff in the management and treatment of Mdm Parvaty. According to the Statement of Claim (“SOC”), these breaches led to the development and worsening of wounds on her right heel and right posterior shin, ultimately necessitating an above-knee amputation (“AKA”). Damages were claimed for the loss and damage allegedly caused by the AKA.
- [4]
[4] The trial before me was not bifurcated as to issues of liability and damage. I make two preliminary points. First, following Mdm Parvaty’s demise on 30 January 2023, the learned Assistant Registrar had – at a case conference on 18 May 2023 – directed counsel for Mdm Parvaty and Mdm Meenachi to file a formal application for the latter to be substituted as the claimant, as opposed to being added as the second claimant. However, counsel did not proceed to do so; and in the course of the trial before me, the Defendants have not raised any real objections to Mdm Parvaty’s name continuing to appear as the first claimant. In the interests of accuracy, however, I will refer only to the “Claimant” in these grounds of decision, on the understanding that this refers to Mdm Meenachi in her capacity as the administrator of Mdm Parvaty’s estate.
- [5]
[5] Second, it should be pointed out that in the SOC, the Claimant pleaded two different causes of action against the Defendants: first, a cause of action in the tort of negligence; and second, a breach of these Defendants’ contractual obligations to Mdm Parvaty. However, the Claimant did not put forward any evidence at trial of the contractual terms pleaded in the SOC. In the written submissions filed on her behalf at the end of the trial, the Claimant also did not address the purported breaches of contract. As such, it was not necessary for me to address the claim for breach of contract.
- [6]
[6] At the conclusion of the trial, having considered the evidence and parties’ submissions, I found that the Claimant had failed to establish any of the pleaded breaches of duties; and I dismissed the claim against both Defendants. In so doing, I provided parties with a summary of the grounds for my decision. I now set out the full written grounds.
- [7]
[7] I first outline the factual background to the dispute. For ease of reference, a list of the medical abbreviations used in these written grounds is attached at Annex A herein. A list of the witnesses who testified at trial (including the designation and role of each witness) is attached at Annex B.
Facts
The parties
- [8]
[8] The Claimant’s action against NUH mainly concerned the alleged conduct of three of its doctors who were involved in the care and management of Mdm Parvaty’s case. These doctors were:
(a) Dr Ng Yau Hong (“Dr Ng”), an Orthopaedic surgeon and a Consultant in the Division of Adult Reconstruction and Joint Replacement Surgery in the Department of Orthopaedic Surgery, NUH. Dr Ng was involved in the medical management of Mdm Parvaty during her admission at NUH between 25 September 2020 and 13 January 2021. During that time, Dr Ng was the orthopaedic consultant in charge of Mdm Parvaty’s septic arthritis.
(b) Dr Tham Sai Meng (“Dr Tham”), a specialist in infectious diseases and a consultant in the Division of Infectious Diseases in NUH. Dr Tham was involved in the medical management of Mdm Parvaty between 3 October 2020 and 6 January 2021 as a Year 2 Senior Resident. Dr Tham’s scope of duties included providing specialist advice for patients with suspected or confirmed infections. Dr Tham also provided advice on evaluating and managing infective issues, in consultation with the covering consultant, Associate Professor Chai Yi Ann Louis.
(c) Dr Wong Chi Leung Julian (“Dr Julian Wong”) was the Head of Division of the Vascular and Endovascular Surgery in the Department of Cardiac, Thoracic & Vascular Surgery in NUH at the time of Mdm Parvaty’s admission. Dr Julian Wong was involved in the Vascular team’s management of Mdm Parvaty from 25 September 2020 to 13 January 2021 and from 5 February to 22 March 2021.
- [9]
[9] The Claimant’s action against AMKH mainly concerned the alleged conduct of one of its doctors, Dr He Yingci (“Dr He”), who was a resident physician at AMKH at the material time. Dr He was involved in the management of Mdm Parvaty between 13 January 2021 and 5 February 2021. His duties involved, inter alia, conducting ward rounds, managing acute and chronic medical conditions, updating family members of patients’ progress, and discharge planning.
Background to the dispute
- [10]
[10] Mdm Parvaty first presented at NUH’s emergency department on 6 September 2020 with a complaint of severe pain in her right knee. She was diagnosed as having chronic right knee pain. At the material time, Mdm Parvaty suffered from multiple medical conditions, including end-stage renal failure (“ESRF”) for which she was on haemodialysis, as well as diabetes mellitus, seronegative rheumatoid arthritis, hypertension, hypothyroidism, hyperlipidemia, and severe aortic valve disease.
- [11]
[11] On 9 September 2020, she presented at NUH’s emergency department a second time for worsening right lower limb pain. She underwent a right knee aspiration (the “First NUH Admission”) and was diagnosed with a calcium pyrophosphate dihydrate flare in her right knee. Following some improvement in her right knee, she was discharged from NUH on 19 September 2020.
- [12]
[12] On 25 September 2020, after Mdm Parvaty hit her right knee against the corner of her bed frame, she presented again at NUH’s emergency department with a complaint of right knee pain with swelling (the “Second NUH Admission”). Her right knee was found to have an effusion with warmth. She was advised to undergo right knee arthrocentesis (knee aspiration) on 29 September 2020, but she initially declined. This knee aspiration was eventually done on 1 October 2020, and culture results from the fluid aspirated confirmed gram-positive cocci, which was indicative of right knee septic arthritis. She was started on intravenous antibiotics on the same day.
- [13]
[13] On 2 October 2020, Mdm Parvaty received surgical treatment which included a right knee arthroscopic debridement and washout. According to NUH’s records, the blood and joint fluid cultures isolated Methicillin-Susceptible Staphylococcus Aureus (“MSSA”). Mdm Parvaty was diagnosed with MSSA bacteremia secondary to right knee septic arthritis. Wound dehiscence was noted on 20 October 2020, which indicated the recurrence of her knee infection. On 21 October 2020, Mdm Parvaty underwent a repeat right knee arthrotomy, synovectomy, and washout. There was osteomyelitis (ie, infection of the bone) of the inferior pole of the patella; and 90% of the patella tendon at the patellar insertion site was found to be necrotic and had avulsed off. Septic workup including a 2D echocardiography and PET-CT scan did not reveal a definite source of infection. A plaster back slab was applied on Mdm Parvaty’s right leg post-operation. According to NUH, this back slab was applied in order, firstly, to protect the residual patellar tendon by allowing the knee extensor mechanism to scar down. The second reason for the back slab was wound protection, as Mdm Parvaty’s arthroscopic wounds from the first right knee arthrotomy had dehisced; and she had multiple risk factors for wound breakdown, including diabetes, renal failure, and severe vascular disease.
- [14]
[14] On 2 November 2020, Mdm Parvaty’s knee back slab was converted to a fibreglass cast. It was at this time that she was noted to have a 1.5cm-by-1.5cm deep tissue injury (“DTI”) on her right lateral foot and a 7cm-by-7cm DTI on her right heel. The NUH Orthopaedic team ordered the fibreglass cast to be applied above the ankle to facilitate heel monitoring and dressings; and soft tissue protection strategies, such as the use of foam dressing and appropriate offloading of the heel, were continued. It was not disputed that pressure ulcers were still present on Mdm Parvaty’s right heel and foot as at 11 November 2020.
- [15]
[15] On 29 November 2020, Mdm Parvaty’s right heel wound was assessed by the Infectious Diseases team to have developed into dry gangrene. . The following day, the NUH Orthopaedic team issued a blue letter referral to the Vascular Surgery team requesting that Mdm Parvaty be reviewed for peripheral artery disease (“PAD”) and noting that she had dry gangrene of the right foot secondary to pressure ulcers. Mdm Parvaty was subsequently reviewed by the Vascular team on 1 December 2020; and it was observed that the dry gangrene over her right heel was well-demarcated, with no evidence of ascending cellulitis, infection, bogginess or discharge. An MRI scan on 1 December 2020 showed no signs of osteomyelitis.
- [16]
[16] On 3 December 2020, Mdm Parvaty underwent an arterial ultrasound of her right lower limb, which showed significant stenosis over the mid anterior tibial artery (“ATA”), with a patent peroneal artery (“PA”) all the way to the ankle, and chronic occlusion with minimal flow distally in the posterior tibial artery (“PTA”). The Vascular team assessed that Mdm Parvaty’s right heel wound was likely a heel pressure wound and advised that conservative management be continued, including elevation of her right lower limb and offloading of the right heel.
- [17]
[17] According to NUH, Mdm Parvaty’s right heel gangrene remained dry and was not infected for the remainder of her stay in NUH up to her discharge to AMKH on 13 January 2021. On 6 January 2021, a PET-CT scan was carried out; and it was noted, inter alia, that there was no FDG-avidity over the right heel, which indicated that there was unlikely to be any active infection at that area.
- [18]
[18] Upon admission to AMKH on 13 January 2021, Mdm Parvaty was reviewed by Dr He on the same day. In his notes of the examination, Dr He documented his observation, inter alia, of a right heel eschar with bogginess noted at the eschar.
- [19]
[19] It was not disputed that subsequently, in the course of her stay at AMKH, Mdm Parvaty was reviewed by Dr He and his colleague Dr Sandhya Chandramohan Girijadevi (“Dr Sandhya”) on various occasions between 14 January 2021 and 5 February 2021. On 25 January 2021, during a review carried out by Dr He together with the wound nurse Senior Staff Nurse Siti Rohaidah binte Mohamed (“SSN Siti”), it was observed, inter alia, that Mdm Parvaty’s right heel wound was 100% necrotic with slight bogginess but without odour. It was not disputed that following this review, the wound dressing was changed from spirit dressing to an antiseptic dressing, ie, iodine.
- [20]
[20] On 29 January 2021, during another wound inspection, Dr He noted, inter alia, that the right heel wound was foul smelling with odour present, and boggy when depressed especially along the peripheries. According to AMKH, the frequency of wound inspections was increased in response; and the right heel wound was dressed daily with iodine.
- [21]
[21] According to Dr He’s notes, when he carried out wound inspections on 1 February 2021, the right heel wound was not foul-smelling and also less boggy when depressed. His notes of the next wound inspection on 3 February 2021 similarly recorded his observation that the right heel wound was not foul-smelling and that there was mild bogginess over the peripheries. There was no change in the wound shape. In Dr He’s view, the right heel wound was stable at that point and had returned to its baseline condition on admission.
- [22]
[22] On 5 February 2021, Dr He and Dr Sandhya both observed that Mdm Parvaty’s right heel wound had deteriorated and was exhibiting signs of wet gangrene: inter alia, the right heel was observed to be mildly foul-smelling with purulent exudative discharge. As wet gangrene required an escalation of care, Mdm Parvaty was transferred back to NUH under the care of the Vascular team (the “Third NUH Admission”). Upon Mdm Parvaty’s readmission to NUH, she was observed to have a large foul-smelling right foot wound with purulent discharge.
- [23]
[23] According to NUH, after Mdm Parvaty’s re-admission, the Vascular team ordered a series of tests and also administered antibiotics to her. On 6 February 2021, after reviewing the test results, the Vascular team assessed that Mdm Parvaty had a right gangrenous posterior heel wound against a background of right lower limb critical limb ischaemia (“CLI”). The team noted that she might require either a below knee amputation (“BKA”) or an AKA.
- [24]
[24] A family conference was held on 7 February 2021 to convey the proposed treatment plan, including the possibility of either a BKA or an AKA. According to the Vascular team’s notes of the family conference, they were informed by Mdm Parvaty’s children that Mdm Parvaty had said “she would rather die than have a major amputation”.
- [25]
[25] On 8 February 2021, pursuant to a blue letter referral by the Vascular team, Mdm Parvaty was reviewed by NUH’s Orthopaedics team for the possibility of wound debridement. The Orthopaedics team noted that she had poor pulse in her right lower leg and opined that if revascularisation of her right leg was possible, there might be a chance for the wound to heal with debridement – but if revascularisation was not possible, then debridement was unlikely to succeed, in which case it might be better to do a major amputation. In this connection, vascular scans on 9 February 2021 showed that Mdm Parvaty’s right PTA was entirely occluded, while the mid-ATA was occluded, with 70–99% stenosis at the origin of the peroneal artery and 50-69% of the distal peroneal artery.
- [26]
[26] At the family conference held on the same day (9 February 2021), Mdm Parvaty and her children were informed that the severe occlusion shown in the scans would make revascularisation of the right lower limb technically difficult. They were informed that the overall chance of success of debridement with possible revascularisation was less than 20%; and that the option recommended by the Vascular team was a BKA or an AKA, with an AKA wound being the most likely to heal. The Vascular team’s notes of this family conference noted that Mdm Parvaty and her children were still keen to try for limb salvage, while understanding that this might only be delaying the inevitable need for a major amputation.
- [27]
[27] On 10 February 2021, Dr Julian Wong saw Mdm Parvaty again and explained to her that the heel wound was too deep for revascularisation and debridement. The following day, at another family conference, Mdm Parvaty and her family were told that she required surgical intervention to prevent worsening sepsis and that the first recommendation was to try a BKA. However, according to the Vascular team’s notes of the family conference, Mdm Parvaty was still adamant in opposing any major amputation. As such, the treatment plan at that time was to carry out local debridement to assess the depth of the gangrene first: if the gangrene was found to be superficial, the possibility of proceeding with an angioplasty could be explored; whereas if the gangrene was confirmed to be extensive and the right limb was unsalvageable, then amputation would have to be further considered.
- [28]
[28] On 13 February 2021, the planned debridement of Mdm Parvaty’s right heel wound was carried out by Dr Julian Wong. The operation showed that Mdm Parvaty had a deep abscess collection underneath the necrotic eschar that tracked up her mid-shin, with extensive unhealthy tissue, and unhealthy underlying fascia and tendons. This meant that any revascularisation attempt would be unsuccessful. Mdm Parvaty and her daughter, the Claimant, were informed of these findings on the same day; and the Vascular team repeated their recommendation of major amputation.
- [29]
[29] At the next family conference on 15 February 2021, the Vascular team again explained to Mdm Parvaty’s family the intra-operative findings. The team’s notes of this family conference documented that the family was told: (a) as there was a lot of unhealthy tissue in Mdm Parvaty’s right posterior heel with abscess tracking proximally, it would not be possible to debride the wound adequately to remove all unhealthy tissue; (b) conservative management with antibiotics and wound dressing changes was not recommended as the chances of healing were poor, with the sepsis likely to progress and turn life-threatening; (c) a BKA had a lower chance of wound healing than an AKA; and (d) an AKA had the best chance of healing, but even if a prosthesis were to be fitted post-amputation, Mdm Parvaty was likely to be wheelchair-bound thereafter.
- [30]
[30] According to NUH’s medical records, on 16 February 2021, when seen by Dr Julian Wong and his colleague Dr Bryan Buan, Mdm Parvaty agreed to proceed with amputation, but requested that the surgery be done on 19 February 2021, as 18 February 2021 was the date of her birthday. Informed consent was signed by Mdm Parvaty on 17 February 2021, indicating her consent to a right BKA, with an AKA to be kept in view during the operation.
- [31]
[31] On 19 February 2021, Mdm Parvaty underwent a right AKA. During the operation, it was discovered that her right heel gangrene had infection tracking up her tendoachilles and calf muscles to the mid-calf, which rendered a BKA impossible.
- [32]
[32] Following her recovery from the AKA, Mdm Parvaty was discharged from NUH on 22 March 2021. She was reviewed by NUH’s vascular surgery team on seven occasions following her discharge; and it was noted that her right AKA had healed well.
- [33]
[33] Mdm Parvaty passed away two years later, on 30 January 2023, at the age of 75. It was not disputed that the cause of death was coronary artery disease and ESRF.
Parties’ cases
- [34]
[34] I next summarise the parties’ pleaded cases.
Claimant’s case
- [35]
[35] As I noted earlier, the Claimant pleaded both a cause of action in negligence and a cause of action in breach of contract. However, since the Claimant failed to adduce any evidence of the relevant contract terms and/or to address the purported breach of contract in her closing submissions, I will not address the claim in contract.
- [36]
[36] In respect of the claim in negligence, the Claimant set out in her SOC an extensive list of the Defendants’ alleged breaches of duty. However, in the closing submissions filed on her behalf, the Claimant elected to focus on only a specific few alleged breaches and to forego addressing the other breaches pleaded. Accordingly, these written grounds address only those specific breaches which the Claimant elected to focus on in her closing submissions.
- [37]
[37] In gist, the Claimant’s case against NUH and AMKH rested on three central and related allegations:
(a) First, NUH breached its duty to Mdm Parvaty by: (a) causing Mdm Parvaty to develop a DTI on her right heel; and/or (b) failing to prevent the DTI from developing; and/or (c) causing the DTI to deteriorate; and/or (d) failing to prevent the DTI from deteriorating.
(b) Second, both NUH and AMKH failed to treat Mdm Parvaty’s dry gangrene by debriding it and performing revascularisation by angioplasty in a timeous manner or at all.
(c) Third, both NUH and AMKH caused Mdm Parvaty’s dry gangrene to deteriorate and/or failed to prevent the dry gangrene from deteriorating to the point where extensive tissue death made limb salvage no longer viable.
I elaborate on each of the above allegations.
NUH failed to prevent Mdm Parvaty’s DTI from developing and deteriorating
- [38]
[38] In respect of the allegations about the development of the DTI and its deterioration, the Claimant argued that during Mdm Parvaty’s Second NUH Admission, her condition was attributed by NUH to septic arthritis “without any microbiological study”, and without any “assessment of the level of risk of pressure ulcers”.
- [39]
[39] Further, the Claimant alleged that after Mdm Parvaty underwent right heel debridement on 2 October 2020 and 20 October 2020, NUH failed to ensure that sufficient precautions were adopted to protect her skin, despite NUH being aware that she was a diabetic patient who was especially at risk of developing foot ulcerations. According to the Claimant, right foot elevation and off-loading measures, such as the use of heel protectors, were only commenced on 4 November 2020, when they should have been employed earlier to prevent the DTI from developing. In this connection, the Claimant pointed to the evidence of her expert witness, Mr Phillip Coleridge Smith (“Mr Smith”), who opined in his expert report that the “ulceration of [Mdm Parvaty’s] right foot would have been prevented with adequate nursing care at NUH during the period September [to] December 2020”.
- [40]
[40] In the Claimant’s closing submissions, it was also alleged that the nurses at NUH must have touched Mdm Parvaty’s right foot with their ungloved hands and that their actions likely introduced infection in the right foot.
- [41]
[41] It was the Claimant’s case, therefore, that the above acts and/or omissions by NUH caused the development of the DTI on Mdm Parvaty’s right foot and heel. According to the Claimant, Dr Ng’s failure to send a blue letter referral to the Vascular team immediately upon noticing the DTI on 2 November 2020 or very shortly thereafter meant that the DTI was allowed to deteriorate further and to turn into dry gangrene “which was the death of tissue caused by a lack of blood perfusion”.
NUH failed to perform revascularisation and debridement for Mdm Parvaty during the Second NUH Admission
- [42]
[42] In respect of the management of Mdm Parvaty’s subsequent dry gangrene, the Claimant contended that NUH was cognisant that Mdm Parvaty had CLI as early as 30 November 2020. The Claimant contended that since this condition was characterised by reduced blood flow to the legs and feet, which could in turn lead to tissue loss, non-healing ulcers, and amputation, urgent vascular intervention, ie, angioplasty, should have been carried out by NUH’s Vascular team at a much earlier stage – in December 2020 or January 2021. In this connection, the Claimant pointed to the evidence of her expert Mr Smith, who opined at trial that even if angioplasty could not have been attempted on Mdm Parvaty’s occluded right PTA, NUH could and should have attempted angioplasty on her right PA and ATA. In Mr Smith’s opinion, this would have allowed the ulceration on Mdm Parvaty’s right foot to heal and thereby prevented the need for an AKA.
- [43]
[43] The Claimant also argued that NUH should, in any event, have offered Mdm Parvaty debridement as a treatment option as early as November 2020. It was the Claimant’s case that early debridement of the dry gangrene would have removed the source of her infection and allowed the ulcer to heal.
NUH’s negligence in discharging Mdm Parvaty to AMKH
- [44]
[44] In respect of the management of Mdm Parvaty’s dry gangrene, it was also the Claimant’s case that NUH should have treated her dry gangrene before discharging her to AMKH on 13 January 2021. In this connection, the Claimant relied on Mr Smith’s opinion evidence that photographs taken of Mdm Parvaty’s necrotic right heel showed the presence of extensive necrotic tissue from around early December 2020; and that regardless of whether the 6 January 2021 PET-CT scan revealed signs of infection, this necrotic tissue should have been “managed surgically” and “excised”.
- [45]
[45] Additionally, according to the Claimant, Mdm Parvaty’s follow-up review was unjustifiably delayed to some four to six weeks from her discharge from NUH on 13 January 2021. The Claimant claimed that this delay in the follow-up review was negligent because dry gangrene could deteriorate very rapidly and required close monitoring every two to three days by a physician in a clinical setting.
- [46]
[46] It was also alleged that neither Mdm Parvaty’s right leg ulcers nor her dry gangrene/necrosis was included in the “problem list” that NUH passed over to AMKH upon her discharge; and that NUH failed, in addition, to specify to AMKH the wound care products to be used. The Claimant contended that had NUH supplied AMKH with the relevant information about Mdm Parvaty’s condition, AMKH would have been better equipped to manage Mdm Parvaty’s condition; and that the deterioration of her dry gangrene into wet gangrene would have been thereby prevented.
AMKH’s failure to diagnose and treat Mdm Parvaty appropriately
- [47]
[47] In respect of the deterioration in Mdm Parvaty’s condition following her discharge to AMKH, the Claimant argued in her closing submissions that the following breaches of duty by AMKH caused and/or contributed to the deterioration:
(a) First, AMKH used saline in the wound dressing applied to Mdm Parvaty’s dry gangrene and only switched to iodine on or around 23 January 2021. In her closing submissions, the Claimant argued that since saline was not an antiseptic (unlike iodine), the use of saline up until 23 January 2021 increased the risk of Mdm Parvaty’s dry gangrene worsening or getting infected.
(b) Second, the Claimant claimed that the nursing care provided by AMKH was substandard, as no wound dressing was done for Mdm Parvaty from her admission to AMKH on 13 January until 15 January 2021; and the nursing team only started changing her wound dressing on a daily basis from 25 January 2021 onwards. The AMKH nurses were also alleged to have touched Mdm Parvaty’s right leg with ungloved hands.
(c) Third, the Claimant argued – relying again on Mr Smith’s opinion evidence – that following her admission on 13 January 2021, AMKH should have carried out debridement of Mdm Parvaty’s right leg ulcers and angioplasty on her right lower limb arteries. Further, it was suggested that since dry gangrene could progress quickly to wet gangrene, antibiotics should have been prescribed for Mdm Parvaty even before 5 February 2021.
(d) Fourth, it was alleged that since Dr He had by 30 January 2021 noted a foul smell coming from Mdm Parvaty’s right heel wound, this meant that the wound must have become infected; and AMKH should have transferred Mdm Parvaty back to NUH earlier than 5 February 2021. The Claimant argued that their delay in transferring her back to NUH caused or contributed to her deterioration.
NUH’s failure to perform urgent debridement when Mdm Parvaty was readmitted on 5 February 2021
- [48]
[48] In respect of the deterioration in Mdm Parvaty’s condition following her transfer back to NUH on 5 February 2021, the Claimant argued that this was caused and/or contributed to by NUH’s failure to carry out urgent debridement and angioplasty on either 5 February or 6 February 2021. Relying on Mr Smith’s expert reports, the Claimant argued that had NUH carried out urgent debridement and angioplasty at that earlier stage, it would have limited the infection and made a BKA possible (as opposed to an AKA).
Res ipsa loquitur
- [49]
[49] Aside from the above allegations as to the Defendants’ breaches of their duty of care, the Claimant also stated in her SOC that she was relying “on the doctrine of res ipsa loquitur to establish that the injury to [Mdm Parvaty’s] right leg was caused by the negligence of the Defendants”.
NUH’s case
- [50]
[50] In its defence, NUH accepted that it owed a duty of care to Mdm Parvaty, and that it was vicariously liable for the acts and/or omissions of its doctors and staff vis-à-vis their care and management of Mdm Parvaty. However, NUH asserted that the care provided to her by its doctors and staff was in accordance with the requisite standard of care, and that there were no breaches of its duty of care.
- [51]
[51] In respect of the Claimant’s allegations regarding the care provided to Mdm Parvaty during her Second NUH Admission, NUH asserted that all appropriate measures were taken to avoid the development of DTIs during her admission and stay. The fact that she developed a right heel DTI was not the result of any lapse of care on the part of NUH. From 2 October 2020 until her discharge to AMKH on 13 January 2021, appropriate pressure injury measures were put in place. These measures included:
(a) Applying padding with foam dressing over pressure points on Mdm Parvaty’s right foot;
(b) Offloading Mdm Parvaty’s right heel with a pillow and heel protector;
(c) Regular turning and regular monitoring of Mdm Parvaty’s skin condition; and
(d) Converting the plaster back slab for her knee to a fiberglass cast so that the areas with DTIs could be left exposed, and to facilitate heel monitoring and dressings.
- [52]
[52] In respect of the Claimant’s allegations regarding the development of the right heel DTI and subsequent dry gangrene, NUH asserted that the decision to manage these conditions conservatively was appropriate because Mdm Parvaty was not a suitable candidate for an angioplasty procedure and/or wound debridement of the right heel, nor was there any clinical indication for such treatment options during her Second NUH Admission.
- [53]
[53] In respect of the Claimant’s allegations regarding the decision to discharge Mdm Parvaty to AMKH, NUH contended that by 13 January 2021, she was fit to be discharged to AMKH for step down care. In particular, NUH pointed out the following:
(a) By 3 January 2021, Mdm Parvaty had completed her antibiotic treatment; and her right heel gangrene was dry and not infected as at the point of her discharge to AMKH;
(b) The PET-CT scan on 6 January 2021 did not show any FDG-avidity over the right heel, which indicated that there was unlikely to be any active infection at the area; and
(c) AMKH had the necessary information, facilities, and care available to provide continued management and rehabilitative care to Mdm Parvaty for her condition.
- [54]
[54] In respect of the Claimant’s allegations regarding the deterioration in Mdm Parvaty’s condition during her Third NUH Admission, NUH contended that Mdm Parvaty and her family had been repeatedly advised that the chances of successful limb salvage were low; and in particular, that the right foot debridement procedure carried out on 13 February 2021 had shown that the foot was not salvageable due to the extensive unhealthy tissue. NUH emphasised that Mdm Parvaty had repeatedly been advised as early as 7 February 2021 to undergo a major amputation: any delay in treatment was due to her own persistent refusal to consider amputation.
- [55]
[55] Finally, according to NUH, the Claimant was unable in any event to establish that the pleaded injuries, loss and damage were caused by any breach of duty on NUH’s part , and/or to show any basis for the application of the doctrine of res ipsa loquitur in this case.
AMKH’s case
- [56]
[56] In its defence, AMKH similarly accepted that it owed a duty of care to Mdm Parvaty; and that it was vicariously liable for the acts and/or omissions of its doctors and staff vis-à-vis their care and management of Mdm Parvaty. However, AMKH denied that there was any breach of its duty of care. According to AMKH, the care, treatment, and management provided to Mdm Parvaty during her stay were appropriate at all times and consistent with the relevant professional standard of care.
- [57]
[57] In respect of the Claimant’s allegations regarding the process of Mdm Parvaty’s admission to AMKH on 13 January 2021, AMKH asserted that Mdm Parvaty was fit for admission to AMKH; that it had in place a screening protocol for assessment and acceptance of referred patients; and that this protocol was adhered to in Mdm Parvaty’s case. This included checking the referred patients’ diagnosis, condition, latest parameters, and blood test results before their transfer to AMKH.
- [58]
[58] In respect of the Claimant’s allegations regarding the care provided to Mdm Parvaty during her stay, AMKH denied any lapse in the care, treatment, and management provided by its doctors and staff. Inter alia, AMKH pointed out the following:
(a) When Mdm Parvaty was admitted to AMKH on 13 January 2021, her wounds received proper inspection and treatment. Dr He observed that Mdm Parvaty had a right heel eschar with bogginess noted at the eschar, and ulceration on her right first toe, with no weeping or discharge. These findings were consistent with dry gangrene; and there were no signs of developing infection.
(b) Elevation and offloading of Mdm Parvaty’s right lower limb were done regularly at AMKH.
(c) The responsibility to determine whether an angioplasty was indicated and to advise Mdm Parvaty accordingly lay with NUH. Both debridement and angioplasty were not clinically indicated nor suitable for Mdm Parvaty. As a community hospital, AMKH was, in any event, not equipped to carry out these procedures.
(d) Prior to 5 February 2021, inspections of Mdm Parvaty’s wounds did not reveal any signs of infection. Upon new developments being observed in her right heel wound on 5 February 2021, Mdm Parvaty was promptly sent back to NUH.
(e) Mdm Parvaty had multiple pre-existing conditions at the time of her admission to AMKH, including chronic life-threatening ischaemia (which represented the end stage of PAD). While the care provided at a rehabilitative facility like AMKH was aimed at stabilising the wound condition and keeping the gangrene dry and infection-free as far as possible, wounds could get infected even with the best efforts; and given Mdm Parvaty’s pre-existing conditions, amputation would have been a significant risk regardless.
- [59]
[59] Further and in any event, AMKH contended that even assuming there was a breach of its duty of care, causation of the injuries and the loss pleaded by the Claimant was not made out because, inter alia, Mdm Parvaty’s right leg was already non-salvageable by the time she was admitted to AMKH on 13 January 2021.
- [60]
[60] As for the doctrine of res ipsa loquitur, AMKH took the position that this doctrine had no application on the facts of Mdm Parvaty’s case, because she already had gangrene at the time of her admission to AMKH; and this condition, when seen against her pre-existing end stage PAD, placed her at significant risk of amputation.
- [61]
[61] Finally, AMKH also took the position that the infection of Mdm Parvaty’s wound which led to her requiring AKA, as well as any injury, pain, suffering, and/or loss arising from the AKA, were caused or contributed to by her own acts and/or omissions.
Issues to be determined
- [62]
[62] In light of the parties’ respective cases, the key issues which arose for my determination at trial were as follows:
(a) Whether NUH negligently failed to take sufficient precautions to prevent Mdm Parvaty’s right heel DTI from developing and worsening during her Second NUH Admission;
(b) Whether NUH was negligent in deciding to treat Mdm Parvaty’s dry gangrene conservatively instead of carrying out revascularisation and debridement during her Second NUH Admission;
(c) Whether NUH was negligent in discharging Mdm Parvaty to AMKH on 13 January 2021;
(d) Whether AMKH negligently caused Mdm Parvaty’s dry gangrene to deteriorate; and
(e) Whether NUH was negligent in not performing debridement and/or angioplasty immediately upon or shortly after Mdm Parvaty’s re-admission on 5 February 2021.
- [63]
[63] I address each of these issues in turn.
My decision
The applicable law
- [64]
[64] In order to succeed in her claim in negligence, the Claimant had to establish, inter alia, that: (a) each of the Defendants owed Mdm Parvaty a duty of care; (b) each of the Defendants breached that duty of care by acting (or omitting to act) below the standard required of it; and (c) the Defendants’ breaches caused the injuries, loss and/or damage pleaded (Spandeck Engineering (S) Pte Ltd v Defence Science & Technology Agency [2007] 4 SLR(R) 100 at [21]).
- [65]
[65] In respect of (a), it is uncontroversial that a doctor owes a duty of care to the patient (Hii Chii Kok v Ooi Peng Jin London Lucien [2016] 2 SLR 544 at [60]); and as I noted earlier, the Defendants accepted that they each owed a duty of care to Mdm Parvaty.
- [66]
[66] In respect of (b), the issue of whether a doctor has met the requisite standard of care in relation to his medical diagnosis and treatment is to be determined according to the principles set out by the Court of Appeal in Hii Chii Kok v Ooi Peng Jin London Lucien [2017] 2 SLR 492 (“Hii Chii Kok”).
- [67]
[67] In Hii Chii Kok, the Court of Appeal held that the requisite standard of care in relation to a doctor’s medical diagnosis and treatment (including pre- and post-operative care) was to be determined by the principles established in Bolam v Friern Hospital Management Committee [1957] 1 WLR 582 (“Bolam”) and Bolitho v City and Hackney Health Authority [1998] AC 232 (“Bolitho”). These principles are commonly referred to as the “Bolam test” and the “Bolitho addendum” respectively (Hii Chii Kok at [76] and [102]–[112]).
- [68]
[68] The Bolam test only requires that the defendant’s practice was supported by a responsible body of opinion within the profession, even if there is another body of opinion which disagrees (Hii Chii Kok at [76(c)]). This test is a proxy or a heuristic for determining what a reasonable and competent doctor would do. Its underlying logic is that a reasonable and competent doctor would only do that which at least some responsible body of doctors would do (Hii Chii Kok at [104]).
- [69]
[69] As for the Bolitho addendum, this consists of a two-stage inquiry. At the first stage, the court considers whether the experts holding the opinion directed their minds to the comparative risks and benefits relating to the matter. At the second stage, the court considers whether the opinion was defensible (meaning that it was internally consistent and did not contradict proven extrinsic facts relevant to the matter) (Hii Chii Kok at [76(d)]). The Bolitho addendum is engaged where there is a genuine difference of opinion within the medical community as to what the medical practitioner ought to have done (Armstrong, Carol Ann (executrix of the estate of Peter Traynor, deceased, and on behalf of the dependents of Peter Traynor, deceased) v Quest Laboratories Pte Ltd [2020] 1 SLR 133 (“Armstrong”) at [53] citing Hii Chii Kok at [109]).
- [70]
[70] In evaluating whether the doctor has met the requisite standard of care in any aspect of his interaction with the patient, the courts should apply the relevant tests with reference only to the facts that were known at the time that the material event occurred (Hii Chii Kok at [158]–[159]). Further, where there is conflicting expert evidence (such as in this case), it is not the sheer number of experts articulating a particular opinion that matters. Rather, it is the consistency and logic of the preferred evidence that is paramount (Ilechukwu Uchechukwu Chukwudi v Public Prosecutor [2021] 1 SLR 67 at [247] citing Sakthivel Punithavathi v Public Prosecutor [2007] 2 SLR(R) 983 (“Sakthivel”) at [75]).
- [71]
[71] It was with these general principles in mind that I considered each of the issues below.
Whether NUH failed to implement sufficient precautions to prevent Mdm Parvaty’s DTI from developing and worsening
- [72]
[72] To recapitulate, the Claimant submitted that NUH failed to prevent Mdm Parvaty’s DTI from developing and then worsening by the following acts and/or omissions of its doctors and staff:
(a) There was no assessment of Mdm Parvaty’s level of risk of developing pressure ulcers;
(b) Insufficient precautions were taken to protect Mdm Parvaty’s skin. In so far as right foot elevation and off-loading were eventually implemented, these should have been commenced before 4 November 2020 so as to prevent the DTI from developing.
(c) Dr Ng should have sent the blue letter referral to the Vascular team by 2 November 2020 when the DTI was first noted; and
(d) Wound photographs were not taken regularly and were of poor quality; and the photographs that were taken showed that contact was made with Mdm Parvaty’s leg by “ungloved hands”.
- [73]
[73] I found no merit in the Claimant’s submissions. My reasons were as follows.
- [74]
[74] First, the allegation that NUH failed to assess Mdm Parvaty’s level of risk of developing pressure ulcers was patently untrue. This allegation appeared to be based on a statement by the Claimant’s expert witness Mr Smith in his first medical report that he had been “unable to find an assessment of the level of risk of pressure ulcers” and that this appeared to fall below the standard of adequate nursing care. However, it was not clear what documents Mr Smith had referred to before concluding that no “assessment of the level of risk of pressure ulcers” could be found. In making the above suggestion about the inadequacy of NUH’s nursing care in this area, Mr Smith also qualified his opinion by pointing out that the issue of acceptable nursing practice in the assessment of risk of pressure ulcers and prevention thereof lay outside his field of expertise.
- [75]
[75] More fundamentally, in claiming that NUH failed to carry out any assessment of Mdm Parvaty’s risk of developing pressure ulcers, what the Claimant failed to acknowledge was that Mdm Parvaty’s medical history – including her history of diabetes mellitus, hypertension, hyperlipidemia and severe aortic valve disease – was in fact well-known to NUH even before the Second NUH Admission on 25 September 2020. Inter alia, Dr Julian Wong (NUH’s then Head of Division of Vascular and Endovascular Surgery) testified that Mdm Parvaty had been his patient since 2014, the year in which she started thrice-weekly haemodialysis. It is a known medical fact that patients with diabetes are especially at risk of developing foot ulceration. It was for this reason that NUH performed extensive assessments to ascertain the pressure points on Mdm Parvaty’s body and to implement appropriate measures to prevent DTIs from developing. NUH’s Nurse Naw Hnin Yee Aye (“Nurse Naw”) deposed that as early as 2 October 2020, following the right knee aspiration performed on Mdm Parvaty, she had performed a “head-to-toe” [emphasis added] skin assessment of Mdm Parvaty to determine which parts of her body would be more prone to pressure injuries. Nurse Naw explained that she was aware that Mdm Parvaty was at risk of developing pressure injuries, especially since she had spent a significant amount of time resting and recovering in bed, and was not very mobile. After conducting this “head-to-toe” skin assessment, Nurse Naw instructed the nursing team to implement, inter alia, the following measures to reduce the risk of Mdm Parvaty developing any pressure injuries:
(a) Placing Mdm Parvaty on a pressure reliving mattress (which Mdm Parvaty initially refused);
(b) Applying Cavilon cream on Mdm Parvaty’s sacral area to protect her skin;
(c) Covering the sacral area and lateral side of Mdm Parvaty’s right foot with Mepilex (which is an adhesive foam dressing used to cushion and protect the pressure points);
(d) Placing both Mdm Parvaty’s heels in heel protectors made of foam so as to offload her heels (ie, reduce the pressure placed on the heels); and
(e) On 22 October 2020, after Mdm Parvaty’s right leg had been placed in a back slab, further pressure-reliving measures were implemented, namely, by placing two pillows under her right calf to keep it elevated.
- [76]
[76] Nurse Naw maintained her evidence under cross-examination. She was also able to provide additional details in cross-examination. In relation to the pressure-relieving mattress, for example, she had noted in her Affidavit of Evidence-in-Chief (“AEIC”) Mdm Parvaty’s initial reluctance to lie on a pressure-relieving mattress, which led to her (Nurse Naw) having to explain to the latter the importance of using such a mattress. In cross-examination, Nurse Naw was able to recall that after she spoke to Mdm Parvaty on 2 October 2020 to get her concurrence to the installation of a pressure-relieving mattress, the mattress was ordered that same afternoon and installed on 5 October 2020.
- [77]
[77] I should point out that in alleging that no appropriate pressure relieving measures were put in place by NUH, the Claimant and her counsel appeared to take the position that it was sufficient for her to make the allegation, without doing anything more, and that the onus then fell on NUH to adduce evidence to refute her allegation. This was clearly a misapprehension of the rules of evidence. As the party who was alleging that NUH had failed to implement sufficient precautions to prevent Mdm Parvaty’s DTI from developing and worsening, the Claimant had the legal and the evidential burden of proving this allegation. This meant that the Claimant was required to adduce some (not inherently incredible) evidence of the fact(s) alleged before the evidential burden could shift to NUH: see Britestone Pte Ltd v Smith & Associates Far East, Ltd [2007] 4 SLR(R) 855 at [58]–[60]; ss 103 to 105 of the Evidence Act 1893 (2020 Rev Ed). In respect of the allegation that pressure relieving measures were not implemented, she had to adduce some (not inherently incredible) evidence to bear out this allegation before the evidential burden shifted to NUH. Instead of doing so, the Claimant and her counsel merely sought to rely on bare – and unfortunately, sweeping – assertions, claiming (for example) that the “[nursing] records did not chart any use of pressure reliving mattresses or heel protectors by [NUH]”, and that there was a lack of “even a single photograph by [NUH of the pressure reliving measures being implemented]”. These assertions were, again, patently untrue. I have highlighted earlier Nurse Naw’s evidence about the “head-to-toe” skin assessment she performed on Mdm Parvaty and the pressure-relieving measures she instructed the nursing team to put in place. A perusal of NUH’s nursing records also revealed multiple references to – and photographs of – pressure relieving measures such as right foot elevation and the use of heel protectors being implemented for Mdm Parvaty.
- [78]
[78] In fact, it should be noted that evidence adduced by the Claimant herself corroborated NUH’s evidence about the implementation of pressure relieving measures. For example, photographs exhibited in the Claimant’s supplementary bundle of documents showed Mdm Parvaty’s right leg elevated with a pillow with her right heel also offloaded with a heel protector.
- [79]
[79] Indeed, despite claiming that he was “unable to find an assessment of the level of risk of pressure ulcers”, Mr Smith accepted in his report that “regular pressure area checks were done [by NUH]”; that “Mrs Parvaty was nursed on a pressure relief mattress”; and that Mdm Parvaty’s heel was “treated by elevation and off-loading” – all of which he acknowledged as being “consistent with standard practice” [emphasis added]. In cross-examination, after being shown Nurse Naw’s affidavit evidence as to the various pressure-relieving measure put in place for Mdm Parvaty (see [75] above), Mr Smith conceded that a combination of the pressure-reliving measures described by Nurse Naw would have been appropriate in terms of keeping Mdm Parvaty’s heels offloaded.
- [80]
[80] When Mr Smith was cross-examined on what additional measures he thought NUH should have employed to relieve pressure on Mdm Parvaty’s right heel and to prevent the DTI from developing, he opined that NUH should have “probably [avoided] encasing the heel in the plaster cast” ie, NUH should not have immobilised Mdm Parvaty’s right leg in the back slab. In this connection, however, it was Dr Ng’s evidence that the plaster back slab was necessary for two reasons. First, the repeat right knee arthrotomy, synovectomy and washout on 21 October 2020 had revealed osteomyelitis of the inferior pole of the patella: as a result, there was necrosis of a significant part of Mdm Parvaty’s patellar tendon, which could compromise a critical part of the extensor mechanism and affect her knee function. A plaster back slab was thus ordered to protect the residual patellar tendon attachment and preserve the extensor mechanism by allowing it to scar down. Second, the plaster back slab would provide wound protection. This was in view of Mdm Parvaty’s multiple risk factors for wound breakdown, including diabetes, renal failure, malnutrition, and severe vascular disease. In fact, her initial arthroscopic wounds from the index surgery had dehisced. Immobilisation via the plaster back slab would put the surgical wound over her knee in the optimal tension-free state for healing.
- [81]
[81] Dr Ng’s evidence was not refuted by any opposing medical evidence from the Claimant’s sole expert Mr Smith. On the contrary, in cross-examination, Mr Smith agreed that it was for the orthopaedic team to decide the extent of immobilisation required to prevent any movement on the part of the patient that might tear or stretch the stitches in the knee. As such, the extent of immobilisation needed for Mdm Parvaty’s right leg was a matter for the discretion of the orthopaedic team based on their clinical judgment. Mr Smith agreed that matters such as whether Mdm Parvaty needed a back slab extending from the mid-thigh to the sole thus fell within the orthopaedic surgeon’s field of expertise and were not within his own field of expertise.
- [82]
[82] Having regard to the evidence set out above at [75]–[81], therefore, I found no merit in the Claimant’s allegations about NUH’s failure to prevent the development of Mdm Parvaty’s DTI. On the evidence adduced, I was satisfied that multiple pressure-reliving measures had in fact been implemented by NUH prior to 2 November 2020, and that they continued to be employed after the DTI was first observed. Accordingly, I was satisfied that NUH had met the requisite standard of care in respect of the steps taken to offload Mdm Parvaty’s right heel.
- [83]
[83] Next, the Claimant alleged that Mdm Parvaty should have been referred to the Vascular team as soon as the DTI on her right heel was observed on 2 November 2020, “or by 7 November 2020”. This appeared to be a suggestion that Dr Ng’s decision to issue the blue letter referral to the Vascular team “only” on 30 November 2020 caused or contributed to the worsening of Mdm Parvaty’s DTI.
- [84]
[84] In this connection, the Claimant appeared to take the position, first, that in so far as there was worsening of the DTI, this was represented by the progression of the DTI from pressure ulcer to dry gangrene; and second, that this progression from pressure ulcer to dry gangrene could and should have been prevented by Dr Ng referring Mdm Parvaty to the Vascular team on 2 November 2020 or shortly thereafter.
- [85]
[85] In my view, this position was misconceived for the following reasons. In so far as the DTI was observed to have progressed to dry gangrene on 29 November 2020, Dr Ng’s evidence was that this progression was not unexpected given Mdm Parvaty’s underlying vasculopathy, renal failure and diabetes, coupled with her prolonged immobile state which compromised tissue healing. Pertinently, the dry gangrene on the right heel was observed on 29 November 2020 to be stable, with no evidence of underlying bogginess or surrounding cellulitis. None of this evidence was refuted by the Claimant. Further, no evidence was adduced by the Claimant to establish that referring Mdm Parvaty to the Vascular team on 2 November 2020 or shortly thereafter would have prevented the progression of the DTI to dry gangrene. While Mr Smith opined that he would have expected a “Diabetic Foot team [to] review the lower limb when a foot ulcer had developed in a diabetic patient” and claimed that “this was not done”, he did not elaborate on what he expected would have been done by the “Diabetic Foot team” following such a review that would have prevented the right heel DTI from progressing to dry gangrene.
- [86]
[86] For the reasons set out above, I also found no merit in the allegation that “delayed” referral to the Vascular team caused or contributed to the worsening of Mdm Parvaty’s DTI.
- [87]
[87] In disposing of the claim that NUH failed to take appropriate steps to prevent the development and worsening of Mdm Parvaty’s DTI, I noted that in addition to the above pleaded allegations, the Claimant’s closing submissions brought up two other matters as alleged examples of “substandard nursing care”. According to the Claimant, NUH’s nursing staff failed to photograph Mdm Parvaty’s right heel wounds with any regularity; and the photographs that were taken were of poor quality. In addition, according to the Claimant, NUH nursing staff had touched Mdm Parvaty’s right leg with “ungloved hands” on numerous occasions.
- [88]
[88] Crucially, these additional allegations were never pleaded by the Claimant. It is trite that facts which are material to a party’s claim must be pleaded (How Weng Fan v Sengkang Town Council [2023] 2 SLR 235 (“How Weng Fan”) at [19]; Multi-Pak Singapore Pte Ltd (in receivership) v Intraco Ltd [1992] 2 SLR(R) 382 at [22]–[24]). The general rule is that parties are bound by their pleadings and the court is precluded from deciding matters that have not been put into issue by the parties (How Weng Fan at [18] citing V Nithia (co-administratrix of the estate of Ponnusamy Sivapakiam, deceased) v Buthmanaban s/o Vaithilingam [2015] 5 SLR 1442 at [38] and OMG Holdings Pte Ltd v Pos Ad Sdn Bhd [2012] 4 SLR 231 at [21]).
- [89]
[89] In the present case, while no express objections were voiced by the Defendants when the Claimant’s counsel sought to cross-examine several of their witnesses on the unpleaded issues, this did not assist the Claimant. The case of The “Tian E Zuo” [2019] 4 SLR 475 (“Tian E Zuo”) is instructive. In that case, the plaintiff’s vessel and the defendant’s vessel were involved in a collision. The plaintiff claimed that this collision was caused by the defendant’s negligence in permitting their vessel to drag her anchor initially (at [2]). In their closing submissions, the plaintiffs also made a number of arguments about the incompetence of the crew on board the defendant’s vessel and urged the court to make a finding on the crew’s incompetence and their resulting lack of bridge management. In response to the defendant’s objection that the issue of incompetence had never been pleaded, the plaintiff sought to persuade the court that their failure to plead this issue was no bar to the court making a finding on it, because the defendant’s witnesses had been cross-examined about this issue during the trial, and “full weight” should be accorded to this aspect of their testimony (at [35]). In rejecting the plaintiff’s argument, Belinda Ang J (as she then was) made the following observation (at [36]):
Having not sought leave to amend the pleadings in the course of the trial, the plaintiffs’ submission that the court could make a finding on an issue that is not pleaded is plainly wrong.
- [90]
[90] In similar vein, I found that the Claimant in this case had ample opportunity to amend her SOC to include the allegations about NUH’s purported failures to ensure regularly staged and good-quality photographs of Mdm Parvaty’s DTI as well as to prevent the alleged contact between the DTI and the nursing staff’s ungloved hands. Having failed to seek leave for such amendments at any stage of these proceedings, the Claimant was not entitled to ask that the court make a determination on these unpleaded matters.
- [91]
[91] Further and in any event, even assuming these unpleaded matters could be considered, no evidence was adduced by the Claimant to establish that either or both of these matters caused or contributed to the development and/or worsening of Mdm Parvaty’s DTI. Mr Smith did not testify that either or both of these matters could have caused or contributed to the development and/or worsening of Mdm Parvaty’s DTI. More to the point, he was not even asked if either or both of these matters could have caused or contributed to the development and/or worsening of the DTI.
Whether NUH was negligent in deciding to treat Mdm Parvaty’s dry gangrene conservatively instead of carrying out debridement and/or angioplasty
- [92]
[92] I next address the claim that NUH breached its duty of care to Mdm Parvaty in deciding to treat her right heel wound conservatively after observing the development of dry gangrene on 2 November 2020. It will be recalled that following the observation of dry gangrene on 2 November 2020, the NUH Orthopaedic team had ordered the application of the fibreglass cast above Mdm Parvaty’s right ankle to facilitate heel monitoring and dressings, as well as the continuation of soft tissue protection strategies such as offloading of the heel. The Claimant’s case was that such conservative management measures were inadequate; and that NUH should instead have carried out debridement of the dry gangrene and revascularisation of Mdm Parvaty’s right lower limb.
Whether NUH should have carried out debridement of Mdm Parvaty’s right heel dry gangrene as soon as possible upon observing it on 29 November 2020
- [93]
[93] I address first the Claimant’s argument that NUH should have carried out debridement of Mdm Parvaty’s dry gangrene as soon as possible upon observing it on 29 November 2020. The Claimant contended that once dry gangrene was observed, NUH should have recognised that there was “almost certain or guaranteed that there would be an underlying infection” underneath the dry gangrene, and should have proceeded to eliminate the source of infection by debriding the dry gangrene. According to the Claimant, doing so earlier would have allowed Mdm Parvaty's wounds to heal and thereby avoided the subsequent need for an AKA.
- [94]
[94] The Claimant’s case was premised on Mr Philip’s opinion. In his testimony at trial, Mr Smith explained the basis for his opinion as follows:
- [95]
[95] To support his opinion, Mr Smith relied on three sets of documents which he tendered at trial:
(a) A set of guidelines issued by the Vascular Society concerning the management of lower limb arterial disease (the “Vascular Society Guidelines”);
(b) A set of guidelines issued by the “National Institute for Health and Care Excellence” (“NICE Guidelines”) which discussed the management of diabetic foot ulceration; and
(c) Chapter 116 of a textbook titled “Rutherford’s Vascular Surgery and Endovascular Therapy” (10th Ed, 2022) (the “Rutherford’s Book”).
- [96]
[96] Mr Smith relied on the NICE Guidelines primarily to suggest that diabetic patients who were already in hospital and who developed a foot ulcer should receive “detailed advice and treatment within one day of the development of their foot ulcer”. As for the Vascular Society Guidelines, he said that these guidelines recommended that persons who presented with an ischaemic ulcer of their leg should – whether or not they are diabetic – “receive investigation and treatment for their lower limb arterial disease within five days”. Mr Smith also referred to the following passage in the Rutherford’s Book to explain the basis for wound debridement:
- [97]
[97] In response, NUH submitted that:
(a) The three sources cited by Mr Smith did not support his opinion.
(b) Mr Smith’s view that dry gangrene must be removed as soon as possible was not shared by any of the other expert witnesses. Mdm Parvaty’s dry gangrene showed no signs of infection prior to her discharge to AMKH on 13 January 2021. Moreover, the other experts’ evidence was that the dry gangrene acted like a biological dressing or plaster between the tissue under the gangrene and the external environment, thus preventing infection.
(c) Mr Smith’s opinion that debridement should have been performed by early December 2020, because Mdm Parvaty’s infection had presumably resolved by early November 2020, was misconceived, and in any event, it would have been risky for Mdm Parvaty to undergo wound debridement given her co-morbidities.
(d) In any event, surgical debridement could not have been carried out on its own; it would have had to be coupled with revascularisation of the debrided region because otherwise, Mdm Parvaty would have ended up with a non-healing wound which would be worse than if nothing had been done. Revascularisation procedures such as angioplasty were neither appropriate nor clinically indicated for Mdm Parvaty during her Second NUH Admission.
- [98]
[98] Having considered the evidence adduced and the parties’ submissions, I accepted NUH’s submissions. My reasons were as follows.
(1) The sources cited by Mr Smith did not support his opinion that there should have been early debridement of Mdm Parvaty’s right heel dry gangrene
- [99]
[99] First, I agreed with NUH that the three sources cited by Mr Smith did not actually support his proposition that there should have been early debridement of Mdm Parvaty’s right heel dry gangrene during her Second NUH Admission.
- [100]
[100] In respect of the NICE Guidelines, these appeared to be broad in nature; and while they recommended as a general guiding principle the initiation of “care” for inpatients with diabetic foot problems within 24 hours, there was no specific injunction to carry out wound debridement for such patients within that time-frame, or indeed, within any particular time-frame. There was also no specific consideration of the sort of wound treatment which would be most appropriate for patients with similar co-morbidities and wound conditions to Mdm Parvaty’s.
- [101]
[101] Similarly, as Mr Smith himself acknowledged during cross-examination, the Vascular Society Guidelines offered only broad recommendations, leaving the final interpretation regarding the timing and appropriateness of any endovascular interventions to the treating clinicians – ie, Mdm Parvaty’s medical team at the material time.
- [102]
[102] Clearly, therefore, both the above sources were broad-based guidelines which could not be relied on to establish the specific standard of care applicable to a patient with Mdm Parvaty’s co-morbidities and wound conditions.
- [103]
[103] As for the principles pertaining to wound debridement outlined in the Rutherford's Book, as I explain in the subsequent portion of these written grounds, Mr Smith’s reliance on the stated principles failed to take into account Mdm Parvaty’s multiple co-morbidities and the resulting implications for any proposed wound debridement (see [107]–[113] below).
(2) Mdm Parvaty’s dry gangrene showed no signs of infection in December 2020 to 13 January 2021
- [104]
[104] Next, Mr Smith’s assertion that there must certainly have been infection beneath the right heel dry gangrene formed one of the key reasons – if not the key reason – for his opinion that the dry gangrene should have been debrided before Mdm Parvaty’s discharge to AMKH. In the reply submissions filed on her behalf, the Claimant sought to support Mr Smith’s opinion by arguing, firstly, that the “speed” at which the dry gangrene had developed into wet gangrene during Mdm Parvaty’s AMKH admission supported the inference that infection must have been present beneath the dry gangrene even before the AMKH admission; and secondly, that the photographs taken of the right heel during the Second NUH Admission showed that the dry gangrene was not stable but was instead “expanding from a slight discolouration on the heel to the blackening of the entire heel”.
- [105]
[105] I rejected Mr Smith’s opinion and the Claimant’s submissions as they were inconsistent with several key pieces of evidence. In particular:
(a) An MRI of Mdm Parvaty’s right heel on 30 November 2020 revealed no underlying abscess and no signs of osteomyelitis.
(b) A PET-CT scan performed on 6 January 2021 revealed no FDG-avidity (ie, no areas of brightness which indicate infection or inflammation) over the right heel. Pertinently, NUH’s vascular expert, Dr Peter Robless (“Dr Robless”) described the PET-CT scan as a “highly sensitive scan” and opined that if there had been any signs of infection, these findings would have been recorded.
- [106]
[106] Given the objective evidence of the state of Mdm Parvaty’s right heel dry gangrene during the Second NUH Admission, I agreed with NUH that there was no evidence of infection beneath the dry gangrene, and that debridement was therefore not indicated prior to her discharge to AMKH.
(3) NUH’s decision to manage Mdm Parvaty’s uninfected dry gangrene conservatively was appropriate
- [107]
[107] Next, Dr Julian Wong was able to provide cogent justification for NUH’s decision to treat Mdm Parvaty’s dry gangrene conservatively. Dr Julian Wong explained that a decision as to how dry gangrene should be treated had to be made within the context of the individual patient’s co-morbidities. As he put it, “[he would] not remove the gangrene for the sake of removing it”.
- [108]
[108] Crucially, Dr Julian Wong explained that dry gangrene which was uninfected actually functioned as “a piece of plaster to protect the tissue underneath”: once that was removed, the patient would have lost “a protective layer of the skin” and a “line of defence” against infection”.
- [109]
[109] The above evidence was corroborated by the following expert witnesses:
(a) Dr Robless testified that leaving dry gangrene on top of the underlying tissue would protect the tissue from external secondary infection. In Dr Robless’ experience, if the dry gangrene was managed appropriately (eg, with 70% alcohol dressing and offloading measures), the care could be done in an out-patient setting – eg in a community hospital or even in the patient’s own home. In Dr Robless’ words, “a lot of this care is done in the community now”.
(b) AMKH’s vascular expert Dr Glenn Tan (“Dr Glenn”) testified that he treated diabetic foot ulcers and gangrene daily; and that if a patient presented with dry gangrene alone, he would not go ahead to debride the gangrene. Instead, he would apply dressings to dry up the gangrene and keep it from getting infected. Dr Glenn further explained that in some cases, dry gangrene on the heel would fall off on its own over time, thereby obviating the need for debridement.
(c) NUH’s orthopaedic expert Dr Tan Tong Leng’s (“Dr Tan”) evidence was that debridement of dry gangrene would cause the patient to lose the “biological barrier” that the dry gangrene would otherwise have provided, leaving the wound “exposed to the elements” and at “very high risk” of developing infection – unless a further “soft tissue resurfacing or flat procedure” was carried out.
(d) NUH’s infectious diseases expert witness, Dr Wong Sin Yew (“Dr Wong SY”) was of the similar opinion that dry gangrene formed a protective covering for the underlying tissue. In his view, having such a “natural covering” was “always better than any form of artificial plaster”, especially because the underlying tissue might not have adequately healed before any attempt to remove the protective covering. Like Dr Glenn, Dr Wong SY also testified that dry gangrene in the heel could “often” be managed conservatively with a view to letting the dry gangrene become “very well defined” and then auto amputating (ie, dropping off by itself).
- [110]
[110] In short, the evidence showed convincingly that there was no infection present beneath Mdm Parvaty’s right heel dry gangrene during her Second NUH Admission; and moreover, that this uninfected dry gangrene functioned as a “biological plaster” which afforded the underlying tissue protection from the external environment, and thus protection from potential infection.
- [111]
[111] Critically, there was also clear evidence that even if debridement of Mdm Parvaty’s right heel dry gangrene was to be considered, it was not something that could be considered in isolation: as Dr Julian Wong noted in his testimony, because debriding the dry gangrene would in effect mean removing the protective covering over the heel wound, any decision to perform wound debridement would first require ensuring adequate blood supply to the affected area, so as to promote healing. Dr Ng, too, gave similar evidence. As Dr Ng put it, once the dry gangrene was “cut open”, the relevant area of the heel would be “exposed to the external environment and … ready for infection”. In order for the heel wound to heal, any debridement had to “come together well” with revascularisation of the lower limb.
- [112]
[112] Dr Julian Wong’s and Dr Ng’s evidence was supported by the expert witness Dr Tan. Dr Tan testified that if Mdm Parvaty’s right heel dry gangrene were to be debrided for any reason, there “must be a plan for revascularisation”, as well as a plan for coverage of the heel area post debridement. As Dr Tan explained:
… The heel is what we term a critical area, meaning to say once you remove the skin away it will expose critical structures, and critical structures are, namely, exposed bone, tendons or neurovascular structures like veins, arteries and nerves. Typically, our coverage strategy will entail a flap or graft … which means we take a portion of a patient's skin or muscle from somewhere … and transpose it and cover a critically exposed area …
… [F]or the flap or graft to survive the surrounding area needs to have good blood flow, or needs to borrow some blood vessel around the heel region for blood supply and already her existing blood flow is extremely poor. there's no additional blood flow to support a flap or graft procedure.
- [113]
[113] Dr Tan testified that with a patient like Mdm Parvaty, one could not simply debride the right heel dry gangrene, and then apply a sterile wound dressing and wait for the wound created by the debridement to heal, because her healing potential would be “quite limited given the almost occluded blood flow” to her heel. In fact, Dr Tan highlighted that if debridement of the right heel dry gangrene were to be performed at all, it would have to be as part of an entire “sequence” and “series” of operations:
The judgment continues past this page. Read the rest at eLitigation.